Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

More Volunteers Needed for Study of AIDS Vaccine


The National Institute of Allergy and Infectious Diseases (NIAD) is seeking volunteers for a study of an experimental AIDS vaccine. At the recent AIDS conference in Stockholm, NIAD deputy clinical director H. Clifford Lane reported that 20 of 60 volunteers have developed an immune response in the study. MicroGensys, a Connecticut firm, manufactured the vaccine from a protein derived from HIV's genetic material. Some volunteers developed flu-like symptoms and fevers lasting up to 24 hours, but there have been no serious side-effects. Volunteers must be gay or bisexual men and must go to Bethesda, Md., once a week for the first month after vaccination and monthly for a year thereafter.


Copyright © 1988 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in July 22, 1988. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.